FDA Says 561 Deaths Linked to Recalled Philips Sleep Apnea Machines
By Lorenz Duchamps The U.S. Food and Drug Administration (FDA) announced in an update this week that previously recalled Philips breathing devices and ventilators used to treat sleep apnea may be linked to hundreds of deaths. In a statement issued on Jan. 31, the FDA said that since April 2021, it has received more than 116,000 medical device reports (MDRs), including 561 reports of…
More Stories
Versarien (LON:VRS) Shares Up 3.4% – Here’s Why
Versarien plc (LON:VRS – Get Free Report)’s share price shot up 3.4% on Monday . The company traded as high...
Ennis (NYSE:EBF) Releases Earnings Results, Meets Estimates
Ennis (NYSE:EBF – Get Free Report) announced its quarterly earnings results on Monday. The industrial products company reported $0.39 EPS...
Head-To-Head Survey: Shopify (NYSE:SHOP) versus Ceridian HCM (NYSE:CDAY)
Shopify (NYSE:SHOP – Get Free Report) and Ceridian HCM (NYSE:CDAY – Get Free Report) are both large-cap computer and technology...
Botswana Diamonds (LON:BOD) Stock Price Up 36.9% – Time to Buy?
Botswana Diamonds plc (LON:BOD – Get Free Report) shares were up 36.9% on Monday . The stock traded as high...
Thermo Fisher Scientific (NYSE:TMO) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank assumed coverage on shares of Thermo Fisher Scientific (NYSE:TMO – Get Free Report) in a...
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given “Market Outperform” Rating at JMP Securities
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “market outperform” rating restated by stock analysts at JMP Securities...